Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 5
2004 2
2005 2
2006 5
2007 10
2008 9
2009 5
2010 4
2011 12
2012 5
2013 6
2014 13
2015 11
2016 12
2017 9
2018 15
2019 20
2020 16
2021 30
2022 15
2023 19
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

205 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean jung ho park (383 results)?
IL-33/Regulatory T-Cell Axis Suppresses Skin Fibrosis.
Cheon SY, Park JH, Ameri AH, Lee RT, Nazarian RM, Demehri S. Cheon SY, et al. Among authors: park jh. J Invest Dermatol. 2022 Oct;142(10):2668-2676.e4. doi: 10.1016/j.jid.2022.03.009. Epub 2022 Mar 25. J Invest Dermatol. 2022. PMID: 35341735 Free PMC article.
Nuclear IL-33 in Fibroblasts Promotes Skin Fibrosis.
Park JH, Mortaja M, Azin M, Nazarian RM, Demehri S. Park JH, et al. J Invest Dermatol. 2023 Jul;143(7):1302-1306.e4. doi: 10.1016/j.jid.2022.12.019. Epub 2023 Jan 26. J Invest Dermatol. 2023. PMID: 36708946 No abstract available.
Stroke and sexual dysfunction - a narrative review.
Park JH, Ovbiagele B, Feng W. Park JH, et al. J Neurol Sci. 2015 Mar 15;350(1-2):7-13. doi: 10.1016/j.jns.2015.02.001. Epub 2015 Feb 7. J Neurol Sci. 2015. PMID: 25682327 Review.
Efficacy and safety of oxiracetam in patients with vascular cognitive impairment: A multicenter, randomized, double-blinded, placebo-controlled, phase IV clinical trial.
Lim JS, Lee J, Kang Y, Park HT, Kim DE, Cha JK, Park TH, Heo JH, Lee KB, Park JM, Oh MS, Kim EG, Chang DI, Heo SH, Park MS, Park H, Yi S, Lee YB, Park KY, Lee SJ, Kim JG, Lee J, Cho KH, Rha JH, Kim YI, Lee JH, Choi JC, Oh KM, Kwon JH, Kim C, Park JH, Jung KH, Sung SM, Chung JW, Lee YS, Kim HY, Cho HJ, Park JW, Moon WJ, Bae HJ. Lim JS, et al. Among authors: park jh. Contemp Clin Trials. 2023 Mar;126:107108. doi: 10.1016/j.cct.2023.107108. Epub 2023 Jan 29. Contemp Clin Trials. 2023. PMID: 36724841 Clinical Trial.
Moderate-Intensity Rosuvastatin Plus Ezetimibe Versus High-Intensity Rosuvastatin for Target Low-Density Lipoprotein Cholesterol Goal Achievement in Patients With Recent Ischemic Stroke: A Randomized Controlled Trial.
Hong KS, Bang OY, Park JH, Jung JM, Lee SH, Song TJ, Nam HS, Park HK, Jung KH, Heo SH, Koo J, Yu KH, Park KY, Kim CK, Park HK, Lee J, Lee J, Seo WK. Hong KS, et al. Among authors: park jh. J Stroke. 2023 May;25(2):242-250. doi: 10.5853/jos.2022.02957. Epub 2023 Apr 11. J Stroke. 2023. PMID: 37032475 Free PMC article.
205 results